&Partners’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
Other funds holding MDT
&Partners's MDT Position: Q2 2026 in Review
&Partners reduced its Medtronic (MDT) stake by 4.7% in Q2 2026, selling an estimated $1.78M and leaving 446,593 shares worth $32.8M. The position accounts for 0.13% of the portfolio, ranked #141.
&Partners first reported a position in MDT in Q2 2021 and has held it in 18 quarters since. The position peaked at $43.2M in Q4 2025. 2,134 funds tracked by Wall St. Rank hold MDT as of Q2 2026.
- &Partners held 446,593 shares of Medtronic worth $32.8M as of Q2 2026.
- &Partners sold 22,020 Medtronic shares in Q2 2026, an estimated $1.78M.
- Medtronic made up 0.13% of &Partners's portfolio in Q2 2026, its #141 holding.
- &Partners first reported a position in Medtronic in Q2 2021 and has held it in 18 quarters since.
- &Partners's Medtronic position peaked at $43.2M in Q4 2025.
- 2,134 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.
Based on &Partners's 13F filing for Q2 2026, filed 14 Aug 2026.